Record Order Book, Guidance Held: The Caution Signal Hiding in Plain Sight
WABAG delivered H1 revenue +20.3% and PAT +30%, hit record order book ₹20,207 Cr, yet reaffirmed full-year guidance rather than raising it. The call reveals why—and the execution risks management is carefully hedging.
₹1,887 Cr
+20.3% YoY | guidance band 15–20%
₹195 Cr
+30% YoY | PAT margin 10.3%, up from 9.6%
₹20,207 Cr
4× annual run-rate | intake ₹5,200 Cr H1
₹1,100+ Cr
15th consecutive quarter positive
On the numbers alone, it looks like a breakout: Q2 revenue crossed ₹1,000 Cr for the first time, profit grew faster than revenue, order book hit a lifetime high at ₹20,207 Cr. But management reaffirmed full-year guidance rather than raising it. That gap—strong delivery, steady guidance—is the story of the quarter. It signals caution, not overconfidence. And the call explains where that caution lives: execution risk on a ₹20K backlog, Middle East geopolitical headwinds eroding near-term margin, and new-sector upside still exploratory. The bull case is real. The bear case is real too. The honest read sits between them.
Order Book: Visibility, Not Inevitability
The order book milestone is genuine. ₹20,207 Cr is not a forecast or a bid pipeline—it is signed contracts with execution visibility spanning 2–4 years. Two projects account for ₹2–3 K of that: Kuwait's 272 MLD seawater reverse-osmosis desalination facility (~USD 400 M equivalent), and Reliance's Jamnagar complex (201 MLD desalination + 72 MLD remineralization + effluent treatment, ~₹1.3 K Cr). These are anchor deals with sovereign or blue-chip backing. But a ₹20K order book is 4× annual revenue. Converting that backlog into cash and profit across 2–4 years is execution, not a fait accompli. Management's caution is warranted: Bangladesh World Bank-funded project is at 90% land acquisition (delays flagged), Saudi Arabia's Al Haer sewage facility is moving slow, and Middle East shipping disruptions are pushing costs. None of this is new news—it's been on management's agenda for quarters—but it is real, and it's not yet fully hedged in margins.
Margin and Mix: O&M Lifting, Inflation Pressing
EBITDA margin held at 14% in H1 (₹261 Cr on ₹1,887 Cr revenue), within the guided 13–15% band. Q2 specifically hit 14.5% (₹145 Cr on ₹1,000 Cr). This is solid: inflation (wage code changes, commodity pricing) would normally compress margin, but WABAG is growing it. Two drivers: (1) O&M (high-margin recurring revenue) is now 18% of H1 revenue, up from 16% in FY26, and management targets 20%; (2) EPC contracts carry escalation clauses for commodity inflation, so pass-through is happening, though with timing lag. The catch: Middle East headwinds are testing that pass-through. Shipping delays to the Gulf have forced alternative routings; commodity prices (steel, chemicals) are under pressure; and some contracts negotiated before recent geopolitical stress don't have full cost recovery. Management says impact is not yet material to H1 margins, but it's a monitoring point for H2.
Earnings quality is strong. PAT grew 30% in H1 versus revenue growth of 20.3%—profit is outpacing sales. Operating cash flow hit ₹225 Cr (>1.1× PAT), and working capital improved to 101 days from 104 days. No major one-time items, no MTM gains propping up the headline. This is organic profit growth.
Record order book crossed ₹20,000 Cr
₹20,207 Cr end-H1 FY27, vs ₹15.7K in Q1. Genuine backlog, not bid pipeline.
Supported
EBITDA margin ~14.5% in Q2 within guided band
Q2 ₹145 Cr / ₹1,000 Cr = 14.5%; H1 14% on ₹1,887 Cr. Within 13–15% band.
Supported
Revenue growth outpacing inflation with +20% YoY
H1 +20.3% YoY, at top of 15–20% guidance band. Q2 +19.9%.
Supported
PAT growth faster than revenue, improving profitability
PAT +23.2% Q2, +30% H1 vs revenue +20%. NPM 10.1% vs 9.6% prior year.
Supported
Net cash crossed ₹1,000 Cr, record high
₹1,100+ Cr (excl. HAM) vs ₹950 Cr FY26 end. 15th consecutive quarter positive.
Supported
Wriddhi 2.0 will unlock next phase of growth
No quantified targets, mechanisms, or timeline disclosed. Details deferred to May 2027 investor meet. Early-stage interactions in semiconductors, data centers, PV solar, hydrogen (no orders yet).
Overstated (aspirational only)
What Changed on This Call
Order book milestone: ₹20,207 Cr (vs ₹15.7K in Q1 FY27). H1 intake ₹5,200 Cr sustains velocity.
Net cash ₹1,100+ Cr (vs ₹950 Cr at FY26 end). 15th consecutive quarter of positive net cash.
EBITDA margin sustained at 14% (within 13–15% band). Not degrading despite inflation.
O&M mix now 18% of revenue (from 16% in FY26), progressing toward 20% target. Higher-margin recurring revenue accelerating.
International revenue now 54% of H1 (MEA, Europe, Asia). Geographic diversification reducing India concentration.
Wriddhi 2.0 strategy announced (5-year roadmap, new sectors: semiconductors, data centers, green hydrogen). No orders yet; upside optionality only.
Guidance reaffirmed, not raised (FY27 revenue CAGR 15–20%, EBITDA 13–15% band maintained). Signal of execution caution despite H1 beat.
Middle East execution headwinds flagged (shipping delays, commodity pricing, geopolitical risk). Margin pass-through mechanism in place but timing lag.
The Bull-Bear Ledger
Order book ₹20.2K Cr (4× revenue) provides multi-year execution visibility
H1 delivered +20.3% revenue, +30% profit (outpaced guidance pace)
Net cash ₹1.1K Cr (15th consecutive quarter positive) reduces financing risk
EBITDA margin sustained at 14% despite inflation (contract escalation clauses working)
O&M mix growing (18% → target 20%); higher-margin recurring revenue stream maturing
Geographic diversification (54% international) reduces India political risk
Payment security (sovereign guarantees, multilateral funding on major projects)
Guidance reaffirmed, not raised, despite H1 beat at top of band (signals execution caution)
Order book conversion risk: ₹20K is 4× annual revenue; execution delays already flagged (Bangladesh 90% land, Saudi slow, shipping disruptions)
Margin sustainability under inflation (pass-through formulae in place but timing lags; Middle East pressure not yet fully absorbed)
New sector strategy (Wriddhi 2.0) exploratory only; no orders booked; 12–15 month gestation before revenue contribution
Pre-tax OCF target dodged on the call (management evasive; no ₹500–600 Cr FY27 commitment given)
Risks, Ranked by Impact on a Holder
Execution slippage on ₹20K order backlog
High₹20.2K Cr order book is 4× annual revenue. Large projects (Kuwait 272 MLD, Reliance ₹1.3K+ Cr, Bangladesh World Bank) span 2–4 years. Delays in land acquisition (Bangladesh 90% done), shipping (Middle East), geopolitical unrest (Saudi slow, Yemen Houthis affecting Red Sea) can compress H2 visibility. Management has track record but risk is real.
Middle East geopolitical and shipping disruption extending into H2
High54% of H1 revenue from international; MEA is ~60–70% of that. Shipping delays have pushed costs; alternative routes (air freight) eroding margins short-term. Escalation pass-through is in place but timing lag creates near-term margin pressure. If geopolitical stress extends, execution timeline may slip further.
Margin sustainability under inflation and wage pressure
MediumEmployee expenses ₹99 Cr in Q2 (on higher end due to Wage Code change one-off impact). Commodity inflation (steel, chemicals, copper) in contracts with delayed pass-through. Guidance reaffirmed (not raised) suggests management caution on margin defense. Inflation not fully hedged yet.
Order book conversion timing risk
Medium₹5.2K Cr H1 intake is strong, but backlog conversion depends on project execution pace. Bangladesh land issues, Saudi delays, Kuwait (mechanical phase ongoing) all flagged. If H2 intake slows or execution delays extend, FY27 revenue growth moderation possible (guidance already reiterated at 15–20% band, not raised).
New sector strategy (Wriddhi 2.0) unproven
MediumSemiconductors, data centers, green hydrogen are new markets for WABAG. Early-stage interactions only; no orders booked. 12–15 month gestation before revenue. Separate team formed but capability/market fit unproven. Details deferred to May 2027. Upside optionality but not yet in guidance; execution risk if cycles lengthen.
Customer concentration (Reliance material in H1)
LowReliance ₹1.3K+ Cr Jamnagar order in H1 (~25%+ of intake). While financially sound and long-term O&M contract visible, large customer concentration is a structural dependency. Other customers (Kuwait, Bangalore, Delhi Jal Board) provide diversification.
How the Street Is Positioned
The stock is trading at ₹2,040.1 with a bullish technical setup: above SMA20 (₹1,880), SMA50 (₹1,973), and SMA200 (₹1,685). RSI at 59.8 is neutral (not overbought). The stock has recovered +97.5% from its 52-week low but sits -12% from its all-time high, suggesting some profit-taking or consolidation after a strong run. Volume is normal (no panic or euphoria selling). On flows: FII holdings increased 49 basis points QoQ to 18.75%, signaling cautious accumulation. DII holdings ticked down 46 basis points to 5.87%, and promoter stake is flat at 19.03%. The FII move is incremental, not a rout—consistent with a "steady positive" narrative rather than a "breakout buy" moment.
Valuation context: At ₹2,040 on an estimated FY27 PAT of ~₹215–225 Cr (extrapolating H1 +30% growth), the stock trades at a P/E of ~9–9.5×, which is reasonable for an infrastructure/water-tech story with order visibility and 20%+ growth. The drawdown from ATH is modest (12%), so the stock is not dramatically discounted. The technical and ownership setup is neutral-to-positive: not oversold, but not euphoric either. This is a "steady state" that could go either way depending on H2 execution.
1 · H2 FY27 order intake and execution pace
Management guided for full-year revenue CAGR 15–20% (at H1 +20.3%, there is room to decelerate slightly and still hit top of band). Watch for (a) new order wins in Q3/Q4 (domestic water/wastewater, international expansion), (b) Kuwait 272 MLD project milestone (Reliance Jamnagar ramp), (c) Bangladesh land acquisition completion, (d) Al Haer Saudi commissioning timeline. If H2 intake slows below ₹2.5–3K Cr or execution delays extend, guidance moderation risk rises.
2 · Wriddhi 2.0 strategy details (May 2027 investor meet)
Management has promised quantified targets, sector breakdown, and execution roadmap for the 5-year growth strategy (semiconductors, data centers, green hydrogen). Look for: (a) addressable market sizing and order pipeline in each vertical, (b) timeline to first orders and contribution to revenue, (c) capital / team requirements. If details are vague or timelines pushed further, upside optionality fades.
3 · Margin trajectory and inflation pass-through
Q2 EBITDA margin held at 14.5% despite wage code impact and commodity inflation. Watch if Q3/Q4 maintains this or compresses. Key indicators: (a) employee expense run-rate normalization post wage code change, (b) commodity pricing trends (steel, chemicals), (c) Middle East shipping cost absorption, (d) contract escalation pass-through timing. If margin falls below 13.5%, near-term profitability concerns rise.
4 · Middle East normalization and supply chain easing
Geopolitical stress (Yemen Houthis, Israel-Gaza) is impacting shipping routes and commodity costs. Watch for (a) Suez/Red Sea shipping normalization, (b) alternative route adoption and cost stabilization, (c) Saudi Arabia project pace (Al Haer). If geopolitical tensions ease and shipping normalizes, margin pressure alleviates and H2 guidance upside becomes credible.
VA TECH WABAG is executing well. H1 revenue +20.3%, PAT +30%, order book ₹20.2K Cr, net cash ₹1.1K Cr—these are not marginal beats, they are substantial. But management's choice to reaffirm guidance rather than raise it, despite hitting the top of the band, is a caution flag. It is not pessimism; it is realism. The order book is real, but 4× revenue is not trivial to convert. Execution risk is material, geopolitical headwinds are pressing, and new sector upside is exploratory. This is a steady, multi-year infrastructure play with genuine order visibility—not a growth inflection. For holders, patience is warranted; the next inflection comes from Wriddhi 2.0 (May 2027) and H2 execution pace. For new entrants, wait for that clarity.
The number to track from here: FY27 revenue run-rate and order intake guidance for FY28. If FY27 lands at ₹2.0K–2.1K Cr (in line with 15–20% CAGR) and H1 FY28 order intake sustains ₹2.5K+ Cr, the order book story remains credible and mid-term growth (15–20% CAGR) is defensible. If either slips, the order book risk rises.
Informational and educational content only. Not investment advice.